Synchronous carcinoma breast with chronic myelogenous leukemia: a rare presentation

Indian J Cancer. 2010 Oct-Dec;47(4):477-9. doi: 10.4103/0019-509X.73558.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzamides
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Carcinoma, Ductal, Breast / pathology*
  • Carcinoma, Ductal, Breast / therapy
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Docetaxel
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Mastectomy
  • Middle Aged
  • Neoplasms, Multiple Primary / pathology*
  • Neoplasms, Multiple Primary / therapy
  • Piperazines / administration & dosage
  • Pyrimidines / administration & dosage
  • Radiotherapy
  • Reverse Transcriptase Polymerase Chain Reaction
  • Selective Estrogen Receptor Modulators / administration & dosage
  • Tamoxifen / administration & dosage
  • Taxoids / administration & dosage

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Selective Estrogen Receptor Modulators
  • Taxoids
  • Tamoxifen
  • Docetaxel
  • Doxorubicin
  • Imatinib Mesylate
  • Cyclophosphamide